List of Tables
Table 1. Angiotensin Receptor Antagonists Market Trends
Table 2. Angiotensin Receptor Antagonists Market Drivers & Opportunity
Table 3. Angiotensin Receptor Antagonists Market Challenges
Table 4. Angiotensin Receptor Antagonists Market Restraints
Table 5. Global Angiotensin Receptor Antagonists Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Angiotensin Receptor Antagonists Revenue Market Share by Company (2019-2024)
Table 7. Global Angiotensin Receptor Antagonists Sales Volume by Company (2019-2024) & (K MT)
Table 8. Global Angiotensin Receptor Antagonists Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Angiotensin Receptor Antagonists Price by Company (2019-2024) & (USD/MT)
Table 10. Key Manufacturers Angiotensin Receptor Antagonists Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Angiotensin Receptor Antagonists Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Angiotensin Receptor Antagonists
Table 13. Global Angiotensin Receptor Antagonists Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiotensin Receptor Antagonists as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Angiotensin Receptor Antagonists Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Angiotensin Receptor Antagonists Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Angiotensin Receptor Antagonists Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Angiotensin Receptor Antagonists Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Angiotensin Receptor Antagonists Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Angiotensin Receptor Antagonists Sales Volume by Type: 2019 VS 2023 VS 2030 (K MT)
Table 22. Global Angiotensin Receptor Antagonists Sales Volume by Type (2019-2024) & (K MT)
Table 23. Global Angiotensin Receptor Antagonists Sales Volume by Type (2025-2030) & (K MT)
Table 24. Global Angiotensin Receptor Antagonists Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Angiotensin Receptor Antagonists Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Angiotensin Receptor Antagonists Price by Type (2019-2024) & (USD/MT)
Table 27. Global Angiotensin Receptor Antagonists Price by Type (2025-2030) & (USD/MT)
Table 28. Global Angiotensin Receptor Antagonists Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Angiotensin Receptor Antagonists Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Angiotensin Receptor Antagonists Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Angiotensin Receptor Antagonists Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Angiotensin Receptor Antagonists Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Angiotensin Receptor Antagonists Sales Volume by Application: 2019 VS 2023 VS 2030 (K MT)
Table 34. Global Angiotensin Receptor Antagonists Sales Volume by Application (2019-2024) & (K MT)
Table 35. Global Angiotensin Receptor Antagonists Sales Volume by Application (2025-2030) & (K MT)
Table 36. Global Angiotensin Receptor Antagonists Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Angiotensin Receptor Antagonists Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Angiotensin Receptor Antagonists Price by Application (2019-2024) & (USD/MT)
Table 39. Global Angiotensin Receptor Antagonists Price by Application (2025-2030) & (USD/MT)
Table 40. Global Angiotensin Receptor Antagonists Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Angiotensin Receptor Antagonists Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Angiotensin Receptor Antagonists Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Angiotensin Receptor Antagonists Sales Value by Region (2019-2024) & (%)
Table 44. Global Angiotensin Receptor Antagonists Sales Value by Region (2025-2030) & (%)
Table 45. Global Angiotensin Receptor Antagonists Sales Volume by Region (K MT): 2019 VS 2023 VS 2030
Table 46. Global Angiotensin Receptor Antagonists Sales Volume by Region (2019-2024) & (K MT)
Table 47. Global Angiotensin Receptor Antagonists Sales Volume by Region (2025-2030) & (K MT)
Table 48. Global Angiotensin Receptor Antagonists Sales Volume by Region (2019-2024) & (%)
Table 49. Global Angiotensin Receptor Antagonists Sales Volume by Region (2025-2030) & (%)
Table 50. Global Angiotensin Receptor Antagonists Average Price by Region (2019-2024) & (USD/MT)
Table 51. Global Angiotensin Receptor Antagonists Average Price by Region (2025-2030) & (USD/MT)
Table 52. Key Countries/Regions Angiotensin Receptor Antagonists Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Angiotensin Receptor Antagonists Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Angiotensin Receptor Antagonists Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Angiotensin Receptor Antagonists Sales Volume, (2019-2024) & (K MT)
Table 56. Key Countries/Regions Angiotensin Receptor Antagonists Sales Volume, (2025-2030) & (K MT)
Table 57. Pfizer Company Information
Table 58. Pfizer Introduction and Business Overview
Table 59. Pfizer Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Pfizer Angiotensin Receptor Antagonists Product Offerings
Table 61. Pfizer Recent Development
Table 62. Novartis Company Information
Table 63. Novartis Introduction and Business Overview
Table 64. Novartis Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 65. Novartis Angiotensin Receptor Antagonists Product Offerings
Table 66. Novartis Recent Development
Table 67. Merck Company Information
Table 68. Merck Introduction and Business Overview
Table 69. Merck Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 70. Merck Angiotensin Receptor Antagonists Product Offerings
Table 71. Merck Recent Development
Table 72. Astra Zeneca Company Information
Table 73. Astra Zeneca Introduction and Business Overview
Table 74. Astra Zeneca Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 75. Astra Zeneca Angiotensin Receptor Antagonists Product Offerings
Table 76. Astra Zeneca Recent Development
Table 77. Jhonson and Johnson Company Information
Table 78. Jhonson and Johnson Introduction and Business Overview
Table 79. Jhonson and Johnson Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 80. Jhonson and Johnson Angiotensin Receptor Antagonists Product Offerings
Table 81. Jhonson and Johnson Recent Development
Table 82. Eli Lilly Company Information
Table 83. Eli Lilly Introduction and Business Overview
Table 84. Eli Lilly Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 85. Eli Lilly Angiotensin Receptor Antagonists Product Offerings
Table 86. Eli Lilly Recent Development
Table 87. Sanofi Company Information
Table 88. Sanofi Introduction and Business Overview
Table 89. Sanofi Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 90. Sanofi Angiotensin Receptor Antagonists Product Offerings
Table 91. Sanofi Recent Development
Table 92. Bristol-Myers Squibb Company Information
Table 93. Bristol-Myers Squibb Introduction and Business Overview
Table 94. Bristol-Myers Squibb Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 95. Bristol-Myers Squibb Angiotensin Receptor Antagonists Product Offerings
Table 96. Bristol-Myers Squibb Recent Development
Table 97. Bayer Company Information
Table 98. Bayer Introduction and Business Overview
Table 99. Bayer Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 100. Bayer Angiotensin Receptor Antagonists Product Offerings
Table 101. Bayer Recent Development
Table 102. GSK Company Information
Table 103. GSK Introduction and Business Overview
Table 104. GSK Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 105. GSK Angiotensin Receptor Antagonists Product Offerings
Table 106. GSK Recent Development
Table 107. Teva Pharmaceutical Company Information
Table 108. Teva Pharmaceutical Introduction and Business Overview
Table 109. Teva Pharmaceutical Angiotensin Receptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 110. Teva Pharmaceutical Angiotensin Receptor Antagonists Product Offerings
Table 111. Teva Pharmaceutical Recent Development
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Angiotensin Receptor Antagonists Downstream Customers
Table 115. Angiotensin Receptor Antagonists Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Angiotensin Receptor Antagonists Product Picture
Figure 2. Global Angiotensin Receptor Antagonists Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Angiotensin Receptor Antagonists Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Angiotensin Receptor Antagonists Sales Volume (2019-2030) & (K MT)
Figure 5. Global Angiotensin Receptor Antagonists Sales Price (2019-2030) & (USD/MT)
Figure 6. Angiotensin Receptor Antagonists Report Years Considered
Figure 7. Global Angiotensin Receptor Antagonists Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Angiotensin Receptor Antagonists Players Sales Volume Ranking (2023) & (K MT)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Angiotensin Receptor Antagonists Revenue in 2023
Figure 10. Angiotensin Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Valsartan Picture
Figure 12. Telmisartan Picture
Figure 13. Losartan Picture
Figure 14. Irbesartan Picture
Figure 15. Azilsartan Picture
Figure 16. Olmesartan Picture
Figure 17. Global Angiotensin Receptor Antagonists Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Angiotensin Receptor Antagonists Sales Value Market Share by Type, 2023 & 2030
Figure 19. Global Angiotensin Receptor Antagonists Sales Volume by Type (2019 VS 2023 VS 2030) & (K MT)
Figure 20. Global Angiotensin Receptor Antagonists Sales Volume Market Share by Type, 2023 & 2030
Figure 21. Global Angiotensin Receptor Antagonists Price by Type (2019-2030) & (USD/MT)
Figure 22. Product Picture of Hypertension
Figure 23. Product Picture of Cardiovascular Diseases
Figure 24. Product Picture of Kidney Diseases
Figure 25. Product Picture of Other
Figure 26. Global Angiotensin Receptor Antagonists Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 27. Global Angiotensin Receptor Antagonists Sales Value Market Share by Application, 2023 & 2030
Figure 28. Global Angiotensin Receptor Antagonists Sales Volume by Application (2019 VS 2023 VS 2030) & (K MT)
Figure 29. Global Angiotensin Receptor Antagonists Sales Volume Market Share by Application, 2023 & 2030
Figure 30. Global Angiotensin Receptor Antagonists Price by Application (2019-2030) & (USD/MT)
Figure 31. North America Angiotensin Receptor Antagonists Sales Value (2019-2030) & (US$ Million)
Figure 32. North America Angiotensin Receptor Antagonists Sales Value by Country (%), 2023 VS 2030
Figure 33. Europe Angiotensin Receptor Antagonists Sales Value (2019-2030) & (US$ Million)
Figure 34. Europe Angiotensin Receptor Antagonists Sales Value by Country (%), 2023 VS 2030
Figure 35. Asia Pacific Angiotensin Receptor Antagonists Sales Value (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Angiotensin Receptor Antagonists Sales Value by Country (%), 2023 VS 2030
Figure 37. South America Angiotensin Receptor Antagonists Sales Value (2019-2030) & (US$ Million)
Figure 38. South America Angiotensin Receptor Antagonists Sales Value by Country (%), 2023 VS 2030
Figure 39. Middle East & Africa Angiotensin Receptor Antagonists Sales Value (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Angiotensin Receptor Antagonists Sales Value by Country (%), 2023 VS 2030
Figure 41. Key Countries/Regions Angiotensin Receptor Antagonists Sales Value (%), (2019-2030)
Figure 42. Key Countries/Regions Angiotensin Receptor Antagonists Sales Volume (%), (2019-2030)
Figure 43. United States Angiotensin Receptor Antagonists Sales Value, (2019-2030) & (US$ Million)
Figure 44. United States Angiotensin Receptor Antagonists Sales Value by Type (%), 2023 VS 2030
Figure 45. United States Angiotensin Receptor Antagonists Sales Value by Application (%), 2023 VS 2030
Figure 46. Europe Angiotensin Receptor Antagonists Sales Value, (2019-2030) & (US$ Million)
Figure 47. Europe Angiotensin Receptor Antagonists Sales Value by Type (%), 2023 VS 2030
Figure 48. Europe Angiotensin Receptor Antagonists Sales Value by Application (%), 2023 VS 2030
Figure 49. China Angiotensin Receptor Antagonists Sales Value, (2019-2030) & (US$ Million)
Figure 50. China Angiotensin Receptor Antagonists Sales Value by Type (%), 2023 VS 2030
Figure 51. China Angiotensin Receptor Antagonists Sales Value by Application (%), 2023 VS 2030
Figure 52. Japan Angiotensin Receptor Antagonists Sales Value, (2019-2030) & (US$ Million)
Figure 53. Japan Angiotensin Receptor Antagonists Sales Value by Type (%), 2023 VS 2030
Figure 54. Japan Angiotensin Receptor Antagonists Sales Value by Application (%), 2023 VS 2030
Figure 55. South Korea Angiotensin Receptor Antagonists Sales Value, (2019-2030) & (US$ Million)
Figure 56. South Korea Angiotensin Receptor Antagonists Sales Value by Type (%), 2023 VS 2030
Figure 57. South Korea Angiotensin Receptor Antagonists Sales Value by Application (%), 2023 VS 2030
Figure 58. Southeast Asia Angiotensin Receptor Antagonists Sales Value, (2019-2030) & (US$ Million)
Figure 59. Southeast Asia Angiotensin Receptor Antagonists Sales Value by Type (%), 2023 VS 2030
Figure 60. Southeast Asia Angiotensin Receptor Antagonists Sales Value by Application (%), 2023 VS 2030
Figure 61. India Angiotensin Receptor Antagonists Sales Value, (2019-2030) & (US$ Million)
Figure 62. India Angiotensin Receptor Antagonists Sales Value by Type (%), 2023 VS 2030
Figure 63. India Angiotensin Receptor Antagonists Sales Value by Application (%), 2023 VS 2030
Figure 64. Angiotensin Receptor Antagonists Industrial Chain
Figure 65. Angiotensin Receptor Antagonists Manufacturing Cost Structure
Figure 66. Channels of Distribution (Direct Sales, and Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
